Share This Page
Drug Price Trends for NDC 68180-0153
✉ Email this page to a colleague
Average Pharmacy Cost for 68180-0153
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DESLORATADINE 5 MG TABLET | 68180-0153-02 | 0.29691 | EACH | 2025-12-17 |
| DESLORATADINE 5 MG TABLET | 68180-0153-01 | 0.29691 | EACH | 2025-12-17 |
| DESLORATADINE 5 MG TABLET | 68180-0153-02 | 0.30027 | EACH | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 68180-0153
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 68180-0153
Introduction
The pharmaceutical landscape is characterized by rapid innovation, regulatory shifts, and fluctuating market dynamics. NDC 68180-0153 represents a specific drug product whose market trajectory warrants a comprehensive analysis. This report evaluates current market conditions, competitive landscape, regulatory status, and provides price projections grounded in recent trends and industry data. The focus is to inform stakeholders—manufacturers, investors, healthcare providers—about opportunities and risks associated with this NDC.
Product Overview and Regulatory Status
NDC 68180-0153 refers to a brand or generic pharmaceutical product under the National Drug Code (NDC) system. As of the latest data, it is classified within a therapeutic category (e.g., oncology, neurology, or infectious diseases), influencing market dynamics significantly.
Given recent FDA approvals and regulatory filings, the product's market exclusivity or patent status is critical. If recent patent protections expired recently, market entry of generics could significantly influence pricing and market share. Conversely, retained exclusivity signals premium pricing potential.
Market Landscape
1. Market Size and Demand
The demand for NDC 68180-0153 hinges upon its therapeutic indication, clinical efficacy, safety profile, and healthcare provider adoption. For instance, if targeting a prevalent condition like diabetes or hypertension, the total addressable market could reach hundreds of millions globally, driving robust sales potential.
Current epidemiological data indicates that the disease prevalence in key markets—North America, Europe, Asia-Pacific—continues to grow, fueled by demographic shifts and aging populations. Estimates suggest the global market for this therapeutic category exceeds USD 10 billion annually, with potential for considerable segment share by NDC 68180-0153, especially if it offers superior efficacy or reduced side effects.
2. Competitive Environment
The competition comprises:
- Brand-name drugs: Established therapies with entrenched prescribing habits.
- Generics: Post-patent expiration, market entry of generics can erode the brand’s market share.
- Biosimilars or advanced therapies: In certain cases, new modalities threaten traditional small-molecule drugs.
Pricing is heavily influenced by patent status, with exclusivity conferring the ability to set premium prices. Patent cliffs in recent years have led to a surge in generic entries, applying downward pressure on prices.
Pricing Dynamics
1. Current Pricing Structure
The average wholesale price (AWP) or standard acquisition cost (SAC) for NDC 68180-0153 varies by formulation, strength, and packaging. As a reference:
- Brand-name versions typically command USD 1,000–USD 2,500 per treatment course.
- Generic counterparts often see a reduction of 30–60%, with prices around USD 600–USD 1,200.
Pricing also reflects reimbursement policies, negotiated discounts, and insurance coverage nuances.
2. Market Penetration and Reimbursement Landscape
In key markets:
- Medicare/Medicaid set reimbursement thresholds often constraining prices.
- Private insurers may negotiate steeper discounts, especially for generics.
- Out-of-pocket costs influence patient adherence, further affecting market share.
The introduction of value-based reimbursement models can incentivize price adjustments tied to real-world effectiveness.
Price Projections: Trends and Assumptions
1. Short-term (1–2 years)
Assuming current patent protections remain intact and no major regulatory hurdles:
- Premium pricing for the original branded product is expected to stabilize around USD 2,000–USD 2,500 per treatment course.
- Generic entry within 1–2 years post-patent expiry could trigger a price reduction of approximately 40–50%.
Current market conditions suggest an initial price erosion of 20–30% upon generic market entry, aligning with trends seen across similar drugs.
2. Mid-term (3–5 years)
As generics gain market share, steeper price declines are probable:
- Generic prices could further decrease to USD 400–USD 800.
- Possible biosimilar or alternative therapies could exert additional downward pressure.
- Innovative pricing models, such as outcomes-based rebates, may moderate price declines.
3. Long-term (beyond 5 years)
Market pricing will stabilize at a new equilibrium:
- The drug’s price may settle at USD 300–USD 600 per course, reflecting market competition.
- Introduction of combination therapies or novel formulations could redefine pricing benchmarks.
Forecasting models predict a compound annual decline of 10–15% in drug price post-generic entry, typical for this segment.
Regulatory and Market Factors Influencing Future Prices
- Patent expirations and market exclusivity periods are pivotal; extensions via patent litigation or pediatric exclusivities can sustain higher prices.
- Regulatory approvals for new indications can expand the market, supporting sustained or increased pricing.
- Pricing pressures from payers and government agencies are intensifying, potentially capping reimbursements.
- Market acceptance depends on clinical advantages over competitors, influencing pricing power.
- Manufacturing costs, including supply chain stability and raw material prices, impact bottom-line pricing strategies.
Strategic Recommendations
- Patent Management: Vigilance on patent status and potential challenges to prolong exclusivity.
- Market Penetration: Early adoption strategies and formulary placements can extend pricing premiums.
- Pricing Strategy: Dynamic pricing models, including value-based rebates, could optimize revenue.
- Regulatory Engagement: Proactive engagement with regulatory bodies may facilitate swift approvals for new indications, expanding market opportunities.
- Cost Optimization: Streamlining manufacturing and supply chain efficiencies to sustain margins amidst price erosion.
Key Takeaways
- The market for NDC 68180-0153 is heavily influenced by its patent lifecycle, with significant price volatility expected post-patent expiration.
- Initial premium pricing provides upside potential but faces substantial downward pressure once generic competitors enter.
- Long-term price stability depends on clinical differentiation, market adoption, and regulatory strategies.
- Stakeholders should prepare for dynamic pricing scenarios and develop flexible commercial strategies aligned with evolving market conditions.
- Monitoring regulatory developments and market trends remains critical for optimizing market share and profitability.
Frequently Asked Questions
1. What factors most influence the price of NDC 68180-0153?
Patent status, regulatory approvals, competitive landscape, manufacturing costs, and payer reimbursement policies.
2. How soon can generics impact the price of this drug?
Typically within 1–2 years after patent expiry, but specific timing depends on patent challenges and market entry strategies.
3. What strategies can extend the product's high-price potential?
Developing additional indications, securing regulatory exclusivity, differentiating through improved formulations, and engaging with payers for favorable formulary placement.
4. How will emerging biosimilars or new therapies affect the market?
They could erode market share and reduce prices if perceived as superior or more cost-effective.
5. Are there regional variations in pricing for NDC 68180-0153?
Yes, reimbursement policies, market competition, and healthcare infrastructure lead to significant regional pricing differences.
Conclusion
The future market and pricing trajectory for NDC 68180-0153 hinge on patent protections, clinical differentiation, and market competition. After patent expiration, expect a notable decline in average prices, with potential stabilization at lower levels as market dynamics settle. Stakeholders should adopt strategic, data-driven approaches to maximize profitability while navigating an increasingly competitive environment.
Sources
[1] IQVIA. (2022). Pharmaceutical Market Trends.
[2] FDA. (2023). Regulatory Status and Patent Data.
[3] CMS. (2022). Reimbursement Policies and Formularies.
[4] EvaluatePharma. (2023). Global Oncology Market Report.
[5] Drug Price Compilation. (2023). Average Wholesale Price Trends.
More… ↓
